Pharmacology & Physiology Research Discipline
Understanding of physiological regulation and disease processes, identifying and validating novel drug targets, mechanisms of drug action
(Coordinator, Emma Kidd )
Expertise includes: elucidating mechanisms of drug action at all levels of organisation, from intracellular sites, membranes and cells through to tissues, organs and intact organisms.
Specific methodologies include: in vivo and in vitro cardiovascular and pulmonary pharmacology, cancer therapeutics and neurogenerative diseases, enzyme purification, spectral analysis, immunoassay, radioligand binding, in situ hybridisation, PCR, cDNA analysis, Western analysis and immunoprecipitation, proteome mapping, receptor cloning, cell culture, single cell electrophysiology, live cell imaging, bioluminescence, immunocytochemistry of total and activated proteins and behavioural testing.
Current research interests include:
- cell signalling, especially in cancer and cardiovascular disease
- airway diseases
- smooth muscle pharmacology
- neurodegenerative diseases
- applications of chemo/bioluminescence
Latest News
09/02/2012
New research by Dr Kathryn Taylor of the School of Pharmacy and Pharmaceutical Sciences at Cardiff University has identified the switch which releases zinc into cells, with important implications for a number of diseases.
20/06/2011
Forty years of enthusiasm rewarded
The International Academy of Cardiovascular Sciences award for Innovative Investigators
29/11/2010
The Network of European CNS Transplantation and Restoration (NECTAR) elects Emma Lane as their new President-Elect.